These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 11416140

  • 1. Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines.
    Li G, Harton JA, Zhu X, Ting JP.
    Mol Cell Biol; 2001 Jul; 21(14):4626-35. PubMed ID: 11416140
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D, Qian L, Chen C, Shi M, Yu M, Hu M, Song L, Shen B, Guo N.
    J Immunol; 2009 Feb 15; 182(4):1799-809. PubMed ID: 19201831
    [Abstract] [Full Text] [Related]

  • 3. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y, McDonald J, Perloff E, Butticè G, Schreiber BM, Smith BD.
    Mol Immunol; 2007 Mar 15; 44(7):1709-21. PubMed ID: 16982097
    [Abstract] [Full Text] [Related]

  • 4. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE, Cooper S, Hangoc G, Chang CH.
    Exp Hematol; 2006 Aug 15; 34(8):1078-84. PubMed ID: 16863914
    [Abstract] [Full Text] [Related]

  • 5. TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA.
    Han Y, Zhou ZH, Ransohoff RM.
    J Immunol; 1999 Aug 01; 163(3):1435-40. PubMed ID: 10415044
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M, Song Z, Gorga JC, Ksander B, Ono SJ.
    Invest Ophthalmol Vis Sci; 2004 Sep 01; 45(9):3185-95. PubMed ID: 15326139
    [Abstract] [Full Text] [Related]

  • 7. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development.
    Shi B, Vinyals A, Alia P, Broceño C, Chen F, Adrover M, Gelpi C, Price JE, Fabra A.
    Int J Biochem Cell Biol; 2006 Sep 01; 38(4):544-62. PubMed ID: 16343978
    [Abstract] [Full Text] [Related]

  • 8. Pathologic expression of MHC class II is driven by mitogen-activated protein kinases.
    Martins I, Deshayes F, Baton F, Forget A, Ciechomska I, Sylla K, Aoudjit F, Charron D, Al-Daccak R, Alcaide-Loridan C.
    Eur J Immunol; 2007 Mar 01; 37(3):788-97. PubMed ID: 17304627
    [Abstract] [Full Text] [Related]

  • 9. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
    Croce M, De Ambrosis A, Corrias MV, Pistoia V, Occhino M, Meazza R, Giron-Michel J, Azzarone B, Accolla RS, Ferrini S.
    Oncogene; 2003 Oct 30; 22(49):7848-57. PubMed ID: 14586411
    [Abstract] [Full Text] [Related]

  • 10. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
    Choi YE, Yu HN, Yoon CH, Bae YS.
    Eur J Immunol; 2009 Mar 30; 39(3):858-68. PubMed ID: 19224634
    [Abstract] [Full Text] [Related]

  • 11. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
    Geirsson A, Paliwal I, Lynch RJ, Bothwell AL, Hammond GL.
    Transplantation; 2003 Jul 27; 76(2):387-94. PubMed ID: 12883198
    [Abstract] [Full Text] [Related]

  • 12. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
    Arancibia-Cárcamo CV, Osawa H, Arnett HA, Háskova Z, George AJ, Ono SJ, Ting JP, Streilein JW.
    Eur J Immunol; 2004 Feb 27; 34(2):471-80. PubMed ID: 14768052
    [Abstract] [Full Text] [Related]

  • 13. The MHC class II transactivator (CIITA) mRNA stability is critical for the HLA class II gene expression in myelomonocytic cells.
    De Lerma Barbaro A, Procopio FA, Mortara L, Tosi G, Accolla RS.
    Eur J Immunol; 2005 Feb 27; 35(2):603-11. PubMed ID: 15627980
    [Abstract] [Full Text] [Related]

  • 14. Adenosine signaling inhibits CIITA-mediated MHC class II transactivation in lung fibroblast cells.
    Fang M, Xia J, Wu X, Kong H, Wang H, Xie W, Xu Y.
    Eur J Immunol; 2013 Aug 27; 43(8):2162-73. PubMed ID: 23681904
    [Abstract] [Full Text] [Related]

  • 15. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
    Takamura Y, Ikeda H, Kanaseki T, Toyota M, Tokino T, Imai K, Houkin K, Sato N.
    Glia; 2004 Mar 27; 45(4):392-405. PubMed ID: 14966870
    [Abstract] [Full Text] [Related]

  • 16. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
    Goodwin BL, Xi H, Tejiram R, Eason DD, Ghosh N, Wright KL, Nagarajan U, Boss JM, Blanck G.
    Cell Growth Differ; 2001 Jun 27; 12(6):327-35. PubMed ID: 11432807
    [Abstract] [Full Text] [Related]

  • 17. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA, Rimsza LM, Murphy SP.
    Exp Hematol; 2009 Feb 27; 37(2):184-194. PubMed ID: 19081173
    [Abstract] [Full Text] [Related]

  • 18. Revisiting the specificity of the MHC class II transactivator CIITA in vivo.
    Otten LA, Leibundgut-Landmann S, Huarte J, Kos-Braun IC, Lavanchy C, Barras E, Borisch B, Steimle V, Acha-Orbea H, Reith W.
    Eur J Immunol; 2006 Jun 27; 36(6):1548-58. PubMed ID: 16703565
    [Abstract] [Full Text] [Related]

  • 19. Regulation of the class II and class I MHC pathways in human THP-1 monocytic cells by interleukin-27.
    Feng XM, Liu N, Yang SG, Hu LY, Chen XL, Fang ZH, Ren Q, Lu SH, Liu B, Han ZC.
    Biochem Biophys Res Commun; 2008 Mar 14; 367(3):553-9. PubMed ID: 18178151
    [Abstract] [Full Text] [Related]

  • 20. CIITA transformation rescues the apoptotic function of MHC class II in melanoma cells.
    Le E, Zhang H, Blanck G.
    Anticancer Res; 2005 Mar 14; 25(6B):3889-92. PubMed ID: 16312044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.